Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 7

Have you been tested and confirmed to have the HLA-A*02:01 genetic marker?

This is a genetic test that determines if you can participate. About 50% of people have this marker. If you haven't been tested, your doctor can do a simple blood test to check.

Show original medical criteria

HLA-A*02:01 positive status is required for this trial because the tebentafusp drug is specifically designed to work with this genetic marker to target cancer cells.

This is informational only — not medical advice. Always discuss eligibility with your oncologist.